Effect of dietary fat and monoclonal antibody therapy on the growth of human mammary adenocarcinoma MX-1 grafted in athymic mice

Cancer Lett. 1990 Jul 31;52(3):173-8. doi: 10.1016/0304-3835(90)90184-y.

Abstract

A diet containing 11% per weight fish oils (Max-EPA) reduced the rate of growth of a transplantable human breast tumor (MX-1) grafted into immunodeficient mice (BALB/c, nu/nu) when compared to MX-1 tumors in mice fed polyunsaturated (corn oil) and saturated (lard) fatty acids; however, there was no difference between the corn oil and lard animal groups. Treatment with a cocktail of monoclonal antibodies (MoAbs) decreased the rat of growth of MX-1 in the corn oil fed animals but not in those fed lard or Max-EPA, but the rate of tumor growth of the Max-EPA treated group, either MoAb treated or not, was slower than that of the corn oil and lard groups.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / diet therapy
  • Adenocarcinoma / therapy*
  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Breast Neoplasms / diet therapy
  • Breast Neoplasms / therapy*
  • Cell Line
  • Dietary Fats
  • Female
  • Fish Oils / therapeutic use*
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Transplantation, Heterologous

Substances

  • Antibodies, Monoclonal
  • Dietary Fats
  • Fish Oils